As with verteporfin, many other compounds, such as CA3 and CPD3.1 [147–149], have also been shown to interfere with YAP/TAZ-TEAD-mediated activity, thereby inhibiting tumor cell growth. This evidence concerns the gene YAP1 and neoplasm.